Drug intelligence / Profile preview

HU1084-DXD

Development stage
Preclinical
Lead developer
Central Institute for Experimental Animals
Modality
Small Molecules, Cytotoxic ADCs → Antibody-Drug Conjugates (ADCs) → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

HU1084-DXD is an **antibody-drug conjugate (ADC)** composed of a humanized anti-tissue factor monoclonal antibody (clone 1084, referred to as hu1084) conjugated to **deruxtecan (DXd)**, a topoisomerase I inhibitor payload, via a cleavable linker. The antibody targets tissue factor (TF), which is highly expressed in several cancers, including pancreatic cancer. Upon binding to TF-positive tumor cells, HU1084-DXD is internalized and releases DXd intracellularly, leading to DNA damage and cell death. Preclinical studies demonstrated that HU1084-DXD exhibits significant antitumor activity in cell line-derived and patient-derived xenograft models of pancreatic cancer.

02

Targets

TOP1 (DNA Topoisomerase I)F3 (Tissue factor)

Beyond the preview

Go deeper on HU1084-DXD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HU1084-DXD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call